Get the Stockscreener App
111.42
0.69%
0.76
After Hours:
111.42
Icon Plc stock is traded at $111.42, with a volume of 798.21K.
It is up +0.69% in the last 24 hours and up +3.03% over the past month.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
See More
Previous Close:
$110.66
Open:
$110.83
24h Volume:
798.21K
Relative Volume:
0.46
Market Cap:
$8.51B
Revenue:
$8.10B
Net Income/Loss:
$599.48M
P/E Ratio:
15.06
EPS:
7.3969
Net Cash Flow:
$971.54M
1W Performance:
+11.43%
1M Performance:
+3.03%
6M Performance:
-42.06%
1Y Performance:
-33.11%
1-Day Range:
$110.33
$112.94
1-Week Range:
$100.25
$112.94
52-Week Range:
$66.57
$211.00
Icon Plc Stock (ICLR) Company Profile
Compare ICLR vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
111.42 | 8.45B | 8.10B | 599.48M | 971.54M | 7.3969 |
TMO
Thermo Fisher Scientific Inc
|
494.54 | 182.60B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
190.79 | 134.18B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
564.66 | 44.63B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.54 | 32.21B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
299.89 | 29.21B | 3.17B | 642.63M | 516.49M | 10.77 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-26-26 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Feb-23-26 | Upgrade | Jefferies | Hold → Buy |
| Feb-18-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-17-26 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Feb-12-26 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-12-26 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jan-08-26 | Downgrade | Truist | Buy → Hold |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-09-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-03-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Aug-21-25 | Downgrade | Citigroup | Buy → Neutral |
| Jul-24-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-29-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-21-25 | Downgrade | Goldman | Buy → Neutral |
| Jan-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Oct-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Neutral |
| Sep-18-24 | Initiated | Leerink Partners | Outperform |
| Jun-06-24 | Initiated | Goldman | Buy |
| Dec-15-23 | Initiated | Truist | Buy |
| Sep-13-23 | Initiated | TD Cowen | Outperform |
| Jan-17-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-13-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Nov-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-07-22 | Initiated | UBS | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-27-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-21 | Initiated | Citigroup | Neutral |
| Apr-13-21 | Resumed | BofA Securities | Neutral |
| Apr-01-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-08-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-03-21 | Initiated | Barclays | Equal Weight |
| Mar-01-21 | Upgrade | UBS | Neutral → Buy |
| Feb-26-21 | Upgrade | Truist | Hold → Buy |
| Jul-24-20 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-20-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-02-20 | Initiated | Deutsche Bank | Hold |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Sep-23-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-26-19 | Upgrade | UBS | Sell → Neutral |
| Jan-25-19 | Upgrade | Mizuho | Neutral → Buy |
| Oct-26-18 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-09-18 | Initiated | UBS | Sell |
| Apr-03-18 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-15-18 | Reiterated | Mizuho | Neutral |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
| Oct-27-17 | Reiterated | Barclays | Equal Weight |
| Sep-11-17 | Initiated | BofA/Merrill | Buy |
| Jul-31-17 | Upgrade | SunTrust | Hold → Buy |
| Jul-27-17 | Reiterated | Mizuho | Neutral |
| Jun-29-17 | Upgrade | Jefferies | Hold → Buy |
View All
Icon Plc Stock (ICLR) Latest News
MEX:ICLR EV-to-OCF: 9.32 — 56% Below Median - GuruFocus
Icon PLC Forges Strategic Alliance Amidst Financial Review - AD HOC NEWS
Icon Plc $ICLR Shares Bought by Allspring Global Investments Holdings LLC - MarketBeat
Icon PLC (ICLR) Stock Price Up 3.93% on Mar 30 - GuruFocus
Precision Trading with Icon Plc (ICLR) Risk Zones - news.stocktradersdaily.com
Is ICON Public Limited Company (ICLR) A Good Stock To Buy Now? - Insider Monkey
ICON Stock Trades At Deep Discount Amid Probe - Let's Data Science
Icon Plc (NASDAQ:ICLR) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Why ICON (ICLR) Is Up 5.1% After New AI-Powered Clinical Trial Partnership With Advarra - simplywall.st
Analysts Offer Insights on Healthcare Companies: Icon (ICLR) and Journey Medical Corp (DERM) - theglobeandmail.com
Clinical research provider Icon stock crashes on accounting probe - MSN
ICON (ICLR) Upgraded by BMO Capital Markets Amid Valuation Appea - GuruFocus
Icon plc buy BMO Capital Markets - sharewise.com
ICON PLC : BMO Raises to Outperform From Mark - Moomoo
BMO Capital Upgrades Icon PLC(ICLR.US) to Buy Rating, Cuts Target Price to $130 - 富途牛牛
BMO upgrades ICON stock rating on pharma backdrop improvement - Investing.com UK
Strategic Partnership Aims to Boost Icon's Efficiency Amid Accounting Scrutiny - AD HOC NEWS
WGI DM, LLC's Icon PLC(ICLR) Holding History - GuruFocus
Icon, Advarra enter partnership, introduces ‘research-ready’ site network model - TipRanks
ICON, Advarra Partner on Connected Site Network Model - Contract Pharma
ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model (1) - PharmiWeb.com
Rep. Julia Letlow Sells Icon Plc (NASDAQ:ICLR) Stock - MarketBeat
ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model - Business Wire
JPMorgan Chase & Co. Sells 614,165 Shares of Icon Plc $ICLR - MarketBeat
ICON set to report delayed earnings after accounting scandal - Investing.com UK
ICON set to report delayed earnings after accounting scandal By Investing.com - Investing.com UK
ICON (ICLR) Is Down 7.8% After Revenue Overstatement Disclosure And Accounting ReviewHas The Bull Case Changed? - Yahoo Finance
Icon Plc $ICLR is Wgi Dm LLC's 4th Largest Position - marketbeat.com
Hudson Bay Capital Management LP Sells 79,000 Shares of Icon Plc $ICLR - MarketBeat
ICON plc (ICLR) CEO details stock option and RSU holdings - Stock Titan
ICON PLC (ICLR) CFO lists RSU and stock option holdings in Form 3 - Stock Titan
ICON PLC (ICLR) director Stephen Cutler reports 79,278 shares and options - Stock Titan
[Form 3] ICON PLC Initial Statement of Beneficial Ownership - Stock Titan
ICON PLC (ICLR) director Linda Grais reports initial share and RSU holdings - Stock Titan
Director Anne Whitaker reports 1,732 ICON PLC (ICLR) restricted share units - Stock Titan
Julie O’Neill (ICLR) details initial ICON PLC share and RSU holdings - Stock Titan
ICON PLC (ICLR) director details shares, RSUs and option holdings - Stock Titan
ICON PLC (NASDAQ: ICLR) director Ronan Murphy details share and option holdings - Stock Titan
ICON PLC (ICLR) director Climax details options, RSUs and share stakes - Stock Titan
ICON PLC (ICLR) director reports initial Form 3 equity holdings - Stock Titan
CIBC Bancorp USA Inc. Invests $39.07 Million in Icon Plc $ICLR - MarketBeat
ICON plc Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators - Markets Mojo
Holocene Advisors LP Sells 287,221 Shares of Icon Plc $ICLR - MarketBeat
Lowey Dannenberg Investigating ICON PLC for Potential Securities Violations - National Today
Lowey Dannenberg Investigating ICON PLC for Potential Securities Law Violations - National Today
Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: ICLR) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm - marketscreener.com
Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: - GlobeNewswire
Icon Plc $ICLR Shares Sold by Fayez Sarofim & Co - MarketBeat
Alliancebernstein L.P. Purchases 53,325 Shares of Icon Plc $ICLR - MarketBeat
ICON (ICLR) Is Down 10.6% After Revenue Restatement And Earnings Delay News Event Has The Bull Case Changed? - Sahm
ICON plc Stock Faces Binary Catalyst as Investigation Nears Verdict on April 30 - AD HOC NEWS
Icon Plc Stock (ICLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):